S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80

Medifast Stock Forecast, Price & News

-3.42 (-1.82%)
(As of 07/6/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
131,789 shs
Average Volume
104,482 shs
Market Capitalization
$2.12 billion
P/E Ratio
Dividend Yield
Price Target

Medifast MarketRank™ Forecast

Analyst Rating
3.00 Rating Score
91.0% Upside
$352.00 Price Target
Short Interest
8.67% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.69mentions of Medifast in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$136,704 Bought Last Quarter
Proj. Earnings Growth
From $15.74 to $19.36 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.99 out of 5 stars

Consumer Staples Sector

2nd out of 196 stocks

Miscellaneous Food Preparations & Kindred Products Industry

1st out of 6 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

Medifast logo

About Medifast (NYSE:MED) Stock

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

MED Stock News Headlines

Medifast (NYSE:MED) Shares Gap Up to $184.17
Short Interest in Medifast, Inc. (NYSE:MED) Expands By 71.8%
Middle Market Leaders 2022: Medifast Inc.
Here's Why Medifast (MED) is a Strong Growth Stock
Medifast, Inc. (MED) To Go Ex-Dividend on June 27th
Medifast, Inc. (NYSE:MED) Announces $1.64 Quarterly Dividend
See More Headlines

Industry, Sector and Symbol

Miscellaneous food preparations & kindred products
Personal Products
Year Founded

Company Calendar

Ex-Dividend for 5/9 Dividend
Last Earnings
Dividend Payable
Ex-Dividend for 8/8 Dividend
Next Earnings (Estimated)
Dividend Payable
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
$164.03 million
Pretax Margin


Sales & Book Value

Annual Sales
$1.53 billion
Cash Flow
$14.45 per share
Book Value
$17.43 per share


Free Float
Market Cap
$2.12 billion

Medifast Frequently Asked Questions

Should I buy or sell Medifast stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Medifast stock.
View analyst ratings for Medifast
or view top-rated stocks.

What is Medifast's stock price forecast for 2022?

1 Wall Street research analysts have issued 12 month price targets for Medifast's stock. Their MED stock forecasts range from $352.00 to $352.00. On average, they predict Medifast's share price to reach $352.00 in the next twelve months. This suggests a possible upside of 91.0% from the stock's current price.
View analysts' price targets for Medifast
or view top-rated stocks among Wall Street analysts.

How has Medifast's stock performed in 2022?

Medifast's stock was trading at $209.43 at the start of the year. Since then, MED stock has decreased by 12.0% and is now trading at $184.25.
View the best growth stocks for 2022 here

Are investors shorting Medifast?

Medifast saw a increase in short interest in June. As of June 15th, there was short interest totaling 989,100 shares, an increase of 71.8% from the May 31st total of 575,700 shares. Based on an average trading volume of 117,700 shares, the days-to-cover ratio is presently 8.4 days. Currently, 8.7% of the company's stock are short sold.
View Medifast's Short Interest

When is Medifast's next earnings date?

Medifast is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Medifast

How were Medifast's earnings last quarter?

Medifast, Inc. (NYSE:MED) posted its quarterly earnings data on Monday, May, 2nd. The specialty retailer reported $3.59 earnings per share for the quarter, topping the consensus estimate of $3.56 by $0.03. The specialty retailer earned $417.60 million during the quarter, compared to analyst estimates of $415.20 million. Medifast had a trailing twelve-month return on equity of 81.42% and a net margin of 10.28%.
View Medifast's earnings history

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Saturday, June 18th. Stockholders of record on Tuesday, June 28th will be given a dividend of $1.64 per share on Monday, August 8th. This represents a $6.56 annualized dividend and a yield of 3.56%. The ex-dividend date is Monday, June 27th.
View Medifast's dividend history

Is Medifast a good dividend stock?

Medifast(NYSE:MED) pays an annual dividend of $6.56 per share and currently has a dividend yield of 3.50%. Medifast has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Medifast is 46.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Medifast will have a dividend payout ratio of 33.88% next year. This indicates that Medifast will be able to sustain or increase its dividend.
View Medifast's dividend history.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $14.60-$16.05 for the period, compared to the consensus EPS estimate of $15.62. The company issued revenue guidance of $1.78 billion-$1.84 billion, compared to the consensus revenue estimate of $1.77 billion.

Who are Medifast's key executives?

Medifast's management team includes the following people:
  • Mr. Daniel R. Chard, Exec. Chairman & CEO (Age 57, Pay $3.45M) (LinkedIn Profile)
  • Mr. James P. Maloney CPA, Chief Financial Officer (Age 54, Pay $1.13M)
  • Mr. Anthony E. Tyree, Chief Marketing Officer (Age 56, Pay $964.79k)
  • Mr. Nicholas M. Johnson, Pres of Coach & Client Experience (Age 42, Pay $1.01M)
  • Ms. Lauren Walker, Exec. VP of Supply Chain Operations (Age 55, Pay $1.07M)
  • Mr. Jonathan Barrett MacKenzie, VP of Fin. & Chief Accounting Officer (Age 50)
  • Mr. Jason L. Groves Esq., Exec. VP, Gen. Counsel & Corp. Sec. (Age 51)
  • Ms. Claudia C. Greninger, Exec. VP of HR (Age 49)

What is Daniel Chard's approval rating as Medifast's CEO?

44 employees have rated Medifast CEO Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among Medifast's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM).

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $184.25.

How much money does Medifast make?

Medifast (NYSE:MED) has a market capitalization of $2.12 billion and generates $1.53 billion in revenue each year. The specialty retailer earns $164.03 million in net income (profit) each year or $14.02 on an earnings per share basis.

How many employees does Medifast have?

Medifast employs 984 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The official website for Medifast is www.medifast1.com. The specialty retailer can be reached via phone at (410) 581-8042, via email at ir@choosemedifast.com, or via fax at 410-581-8070.

This page (NYSE:MED) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.